FOR PHYSICIANS, PROVIDERS AND RESEARCHERS
Let us
help you to
help patients
We partner with leading clinicians, researchers and providers to help cancer patients everywhere while improving your practice.
RESEARCH PARTNERSHIPS
Join our mission to help cancer patients live better, not just longer
Our team at Luminate is developing new technology to improve quality of life for cancer patients. Our flagship treatments for hair loss is currently in clinical trials to verify the benefit to patients. Potential partnerships include involvement in clinical trials of our active products or in our earlier stage clinical research in preventing chemotherapy induced infertility and minimising the adverse events associated with vascular access in oncology patients. Participate in our research and bring important benefits to patients and to your practice.
OUR CLINICAL RESEARCH
Collaborate in active clinical and pre-clinical research
Active Clinical Trials in Hair Loss
Clinical Need & Technology
47% of patients consider hair loss the most traumatic aspect of treatment. The Lily Device is a portable cap-like device which uses a novel compression therapy approach to mitigate drug delivery to the hair follicles, improving patient comfort and eliminating administrative barriers for providers.
Benefits for Providers
Provide hair loss treatment with no compromises. The Lily Device is portable and patient operated, meaning no extra time per patient in clinic (saving over 90 minutes per visit against competitors), and no storage or administration requirements.
Clinical Research
Active clinical trials in Europe. Currently recruiting centres in the United States.
Active Clinical Trials in Peripheral Neuropathy
Clinical Need & Technology
Up to 68% of all chemotherapy patients experience CIPN during or after their treatment. Luminate's Lilac device aims to be the world's first comfortable, portable and preventative solution to CIPN, enabling physicians to deliver chemotherapy treatment without compromise.
Benefits for Providers
Lilac will aim to reduce incidence and severity of CIPN, reducing cost of follow up to oncology clinics by an estimated $17k per patient.
Clinical Research
Proof of concept development ongoing. Identifying suitable research partners in the United States and Europe.
Participate in our clinical research
We're delighted to partner with leading physicians and researchers around the world in our mission to enable patients to take control of cancer treatment. Join our clinical research network and you can play a key role in developing new technology to help cancer patients everywhere.